Kuo YH, Huang TH, Yen YH, Lu SN, Wang JH, Hung CH, Chen CH, Tsai MC, Kee KM*. Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency Ablation. Cancers. 2023 June 12;15(12):3156. (SCI)
Kee KM, Chen CH, Hu JT, Huang YH, Wang TE, Chau GY, Chen KH, Chen YL, Lin CC, Hung CF, Huang SF, Liu TW, Ku HY, Huang BS, Wang YP, Tseng HP, Chiang CJ, Lu SN*. Secular Trends of Clinical Characteristics and Survival of Hepatocellular Carcinoma in Taiwan from 2011 to 2019. Viruses. 2022 Dec 31;15(1):126. (SCI)
Kee KM, Chen WM, Hsu NT, Wang JH, Chao WH, Lin YC, Lu SN*. Community-based screening by Anti-HCV reflex HCV Ag test and accessible post-screening care toward elimination of hepatitis C in two hyperendemic townships. J Formos Med Assoc. 2022 Sep;121(9):1850-1856. (SCI)
Chen HY, Lu SN, Hung CH, Wang JH, Chen CH, Yen YH, Kuo YH, Kee KM*. Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation. PLoS One. 2020 Nov 10;15(11):e0242113. (SCI)
Chen CT, Huang WC, Wang JH, Lee CM, Hung CH, Tsai LS, Chen SC, Lin SC, Lu SN, Kee KM*. Endemic hepatitis B and C virus areas are associated with lower prevalence of hyperlipidemia: Ecological and cross-sectional studies. Advances in Digestive Medicine. 2017 June. 4(2):54–60. 台灣消化醫學雜誌
Kee KM, Lu SN*. Diagnostic efficacy of ultrasound in hepatocellular carcinoma diagnosis. Expert Rev Gastroenterol Hepatol. 2017 Apr;11(4):277-279. (Editorial)
Kee KM, Wang JH, Wang CC, Cheng YF, Lu SN*. Hepatocellular Carcinoma associated with Extra-hepatic Primary Malignancy: its Secular change, Clinical Manifestations and Survival. Sci Rep. 2016 Jul 22;6:30156. (SCI)
Kee KM, Hung CH, Wang JH, Lu SN*. Serial changes of clinical parameters in a patient with advanced hepatocellular carcinoma with portal vein thrombosis achieving complete response after treatment with sorafenib. OncoTargets and Therapy. 2014 May;7:829-834. (SCI)
Kee KM, Wang JH, Lin CY, Wang CC, Cheng YF, Lu SN*. Validation of the 7th edition TNM staging system for hepatocellular carcinoma: an analysis of 8,828 patients in a single medical center. Dig Dis Sci. 2013 Sep;58(9):2721-8. (SCI)
Kee KM, Wang JH, Hung CH, Chen CH, Lee CM, Lu SN*. Improvement of thrombocytopenia in hepatitis C-related advanced fibrosis patients after sustained virological response. Dig Dis Sci. 2013 Feb;58(2):556-61. (SCI)
Kee KM, Wang JH, Hung CH, Chen CH, Lee CM, Chang KC, Tseng PL, Yen YH, Lin CY, Lu SN*. Decreased anti-hepatitis C virus titer and associated factors in chronic hepatitis C patients after sustained virological response: a prospective study. J Gastroenterol Hepatol. 2012 Jun;27(6):1106-11. (SCI)
Kee KM, Lu SN*. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan. Oncology. 2011;81 Suppl 1:36-40. (SCI)
Kee KM, Hung CM, Wang JH, Hung CH, Chen PF, Lin KS, Lu SN*. Low accuracy of the national reporting system of acute hepatitis C infection in Taiwan, 1995-2004. J Gastroenterol Hepatol. 2010 Jul;25(7):1289-94. (SCI)
Lin CY, Kee KM(co-first), Wang JH, Lee CM, Chen CL, Changchien CS, Hu TH, Cheng YF, Hsu HC, Wang CC, Chen TY, Lu SN*. Is the Cancer of the Liver Italian Program system an adequate weighting for survival of hepatocellular carcinoma? Evaluation of intrascore prognostic value among 36 subgroups. Liver Int. 2009 Jan;29(1):74-81. (SCI)
Kee KM, Wang JH, Lee CM, Chen CL, Changchien CS, Hu TH, Cheng YF, Hsu HC, Wang CC, Chen TY, Lin CY, Lu SN*. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer. 2007 Jun 15;120(12):2650-5. (SCI)
Kee KM, Lee CM, Wang JH, Tung HD, Changchien CS, Lu SN*, Wang PW. Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: incidence, associated factors and prognosis. J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):319-26. (SCI)
Kee KM, Wang JH*, Lee CM, Changchien CS, Eng HL. Chronic hepatitis C virus infection associated with dermatomyositis and hepatocellular carcinoma. Chang Gung Med J. 2004 Nov;27(11):834-9. Review.
